Manulife (Manufacturers Life Insurance)
SGMO

Manulife (Manufacturers Life Insurance)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,760
Closed -$24K – 3039
2024
Q1 		$24K Hold
35,760
– – ﹤0.01% 2922
2023
Q4 		$19.4K Sell
35,760
-30,480
-46% -$14.1K ﹤0.01% 2939
2023
Q3 		$39.7K Sell
66,240
-316
-0.5% -$338 ﹤0.01% 2950
2023
Q2 		$86.5K Buy
66,556
+14,377
+28% +$19.6K ﹤0.01% 2893
2023
Q1 		$91.8K Hold
52,179
– – ﹤0.01% 2762
2022
Q4 		$164K Sell
52,179
-657,438
-93% -$2.55M ﹤0.01% 2648
2022
Q3 		$3.48M Sell
709,617
-1,808
-0.3% -$9.29K ﹤0.01% 1207
2022
Q2 		$2.95M Buy
711,425
+577
+0.1% +$2.5K ﹤0.01% 1329
2022
Q1 		$4.13M Sell
710,848
-12,103
-2% -$72K ﹤0.01% 1282
2021
Q4 		$5.52K Sell
722,951
-210,458
-23% -$1.83M ﹤0.01% 1215
2021
Q3 		$8.41M Sell
933,409
-3,960
-0.4% -$39.1K 0.01% 1013
2021
Q2 		$11.2M Buy
937,369
+1,299
+0.1% +$14.7K 0.01% 909
2021
Q1 		$11.7M Sell
936,070
-14,139
-1% -$191K 0.01% 879
2020
Q4 		$14.8M Buy
950,209
+1,832
+0.2% +$21.5K 0.01% 724
2020
Q3 		$8.96M Sell
948,377
-1,360
-0.1% -$14.7K 0.01% 837
2020
Q2 		$8.33M Sell
949,737
-5,116
-0.5% -$47.5K 0.01% 855
2020
Q1 		$6.08M Buy
954,853
+4,589
+0.5% +$34K 0.01% 948
2019
Q4 		$7.95M Buy
950,264
+337,607
+55% +$3.1M 0.01% 969
2019
Q3 		$5.63M Buy
612,657
+541,300
+759% +$6.07M 0.01% 1110
2019
Q2 		$769K Buy
71,357
+4,319
+6% +$45.9K ﹤0.01% 1791
2019
Q1 		$639K Buy
67,038
+5,131
+8% +$52.4K ﹤0.01% 1941
2018
Q4 		$710K Sell
61,907
-3,889
-6% -$48.3K ﹤0.01% 1771
2018
Q3 		$1.12M Sell
65,796
-9,314
-12% -$142K ﹤0.01% 1727
2018
Q2 		$1.07M Buy
75,110
+12,669
+20% +$210K ﹤0.01% 1838
2018
Q1 		$1.19M Sell
62,441
-1,345
-2% -$28.8K ﹤0.01% 1738
2017
Q4 		$1.05M Buy
63,786
+813
+1% +$12.1K ﹤0.01% 1823
2017
Q3 		$944K Buy
62,973
+6,627
+12% +$73.3K ﹤0.01% 1829
2017
Q2 		$496K Sell
56,346
-1,457
-3% -$9.35K ﹤0.01% 2296
2017
Q1 		$301K Buy
57,803
+6,133
+12% +$24.6K ﹤0.01% 2544
2016
Q4 		$158K Buy
51,670
+1,162
+2% +$4.23K ﹤0.01% 2971
2016
Q3 		$234K Buy
50,508
+990
+2% +$5.04K ﹤0.01% 2653
2016
Q2 		$286K Buy
49,518
+3,114
+7% +$19.8K ﹤0.01% 2437
2016
Q1 		$266K Buy
46,404
+580
+1% +$3.48K ﹤0.01% 2393
2015
Q4 		$418 Hold
45,824
– – ﹤0.01% 2125
2015
Q3 		$258 Buy
45,824
+1,803
+4% +$14.9K ﹤0.01% 2445
2015
Q2 		$488 Sell
44,021
-972
-2% -$12.5K ﹤0.01% 2137
2015
Q1 		$705 Buy
44,993
+1,601
+4% +$24.8K ﹤0.01% 1890
2014
Q4 		$660 Sell
43,392
-935
-2% -$11.4K ﹤0.01% 1828
2014
Q3 		$478 Sell
44,327
-78,830
-64% -$1.03M ﹤0.01% 2016
2014
Q2 		$1.88M Buy
123,157
+77,056
+167% +$1.11M ﹤0.01% 1341
2014
Q1 		$833 Sell
46,101
-1,024
-2% -$19.7K ﹤0.01% 1754
2013
Q4 		$655 Buy
47,125
+5,767
+14% +$66.4K ﹤0.01% 1894
2013
Q3 		$434 Sell
41,358
-902
-2% -$8.96K ﹤0.01% 2074
2013
Q2 		$330K Buy
+42,260
New +$369K ﹤0.01% 2172

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SGMO Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 35,760 shares — an estimated $24K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $14.8M in Q4 2020. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 35,760 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $24K.
  • Manulife (Manufacturers Life Insurance) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • Manulife (Manufacturers Life Insurance)'s SANGAMO THERAPEUTICS INC position peaked at $14.8M in Q4 2020.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.